Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic approaches. New data suggest that lipid metabolism may play a significant role in regulating the response of immune cells like macrophages to viral infection, thereby affecting the outcome of the disease. Therefore, understanding the role of lipid metabolism could help develop new therapeutic approaches to mitigate the social and economic cost of coronavirus disease 2019 (COVID-19).

Original publication

DOI

10.1042/BSR20210953

Type

Journal article

Journal

Biosci Rep

Publication Date

27/08/2021

Volume

41

Keywords

COVID-19, HDL, Immune system, Metabolomics, SARS-CoV-2, lipids, COVID-19, Homeostasis, Humans, Lipid Metabolism, Lipidomics, Pandemics, SARS-CoV-2